Biological processes and occurrence numbers of GO in non-tumor tissues with activated low expression of AMELY upstream regulation networks and the corresponding HCC tissues with high expression (fold change ≥2) were identified and computed (Tables I and II). The gene discussed is AMELY; the disease is hepatocellular carcinoma.